Article
Development of a genetic marker set to diagnose aspirin-exacerbated respiratory disease in a genome-wide association study.
The pharmacogenomics journal - 1 Aug 2015
Chang H S, Shin S W, Lee T H, Bae D J, Park J S, Kim Y H, Uh S T, Choi B W, Kim M K, Choi I S, Park B L, Shin H D, Park C S
Abstract excerpt
We developed a genetic marker set of single nucleotide polymorphisms (SNPs) by summing risk scores of 14 SNPs showing a significant association with aspirin-exacerbated respiratory disease (AERD) from our previous 660 W genome-wide association data. The summed scores were higher in the AERD than in the aspirin-tolerant asthma (ATA) group (P=8.58 × 10(-37)), and were correlated with the percent decrease in forced...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
